EPSycon-COVID: Assessment of Neurological, Epidemiological, Psychiatric and Psychosocial Consequences during the COVID -19 Pandemicâ?? - NEPSycon-COVID

IHRLiverppol University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Methodology:
•Participants: All neurological patients visiting the neurological emergency with the following inclusion and exclusion criteria will be included into the study:
•a.Patients of Neurological disorders with previously described symptoms related to COVID-19 infection such as: Young Stroke (cerebrovascular accident), Stroke (cerebrovascular accident) patients with deranged prothrombotic states/elevated D-dimer assays, Acute encephalitis, Seizure of unknown etiology, Guillain barre syndrome, Myositis with elevated CPK, para-infectious neurological disorders in the form of myelitis, ADEM, CNS Demyelinating disorders
•b.Patients of neurological disorders precipitated or preceded by respiratory symptoms in the last 2-4 weeks
•c.Patients of neurological symptoms (not fitting the criteria of a/b) but found to have lymphopenia / thrombocytopenia /thrombotic states / elevated D-dimer levels
•2.Exclusion criteria:
•a.Patients of neurological disorders with a known etiology other than COVID-19
•b.Not giving consent for the study
•Patients of neurological disorders with suspected COVID-positivity will be included into the study after fulfilling the inclusion and exclusion criteria. Then, they will undergo following assessment for further characterization of the neurological symptoms and signs.

发起方

IHRLiverppol University